1 Market Overview

• 1.1 Product Overview and Scope of mRNA Flu Vaccine
• 1.2 Classification of mRNA Flu Vaccine by Type
  • 1.2.1 Overview: Global mRNA Flu Vaccine Market Size by Type: 2026 Versus 2032
  • 1.2.2 Global mRNA Flu Vaccine Revenue Market Share by Type in 2032
  • 1.2.3 mRNA-1010
  • 1.2.4 mRNA-1020
  • 1.2.5 mRNA-1030
• 1.3 Global mRNA Flu Vaccine Market by Application
  • 1.3.1 Overview: Global mRNA Flu Vaccine Market Size by Application: 2026 Versus 2032
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global mRNA Flu Vaccine Market Size & Forecast
• 1.5 Market Drivers, Restraints and Trends
  • 1.5.1 mRNA Flu Vaccine Market Drivers
  • 1.5.2 mRNA Flu Vaccine Market Restraints
  • 1.5.3 mRNA Flu Vaccine Trends Analysis

2 Company Profiles

• 2.1 Moderna
  • 2.1.1 Moderna Details
  • 2.1.2 Moderna Major Business
  • 2.1.3 Moderna mRNA Flu Vaccine Product and Solutions
  • 2.1.4 Moderna Recent Developments and Future Plans
• 2.2 BioNTech
  • 2.2.1 BioNTech Details
  • 2.2.2 BioNTech Major Business
  • 2.2.3 BioNTech mRNA Flu Vaccine Product and Solutions
  • 2.2.4 BioNTech Recent Developments and Future Plans
• 2.3 Sanofi
  • 2.3.1 Sanofi Details
  • 2.3.2 Sanofi Major Business
  • 2.3.3 Sanofi mRNA Flu Vaccine Product and Solutions
  • 2.3.4 Sanofi Recent Developments and Future Plans
• 2.4 Curevac
  • 2.4.1 Curevac Details
  • 2.4.2 Curevac Major Business
  • 2.4.3 Curevac mRNA Flu Vaccine Product and Solutions
  • 2.4.4 Curevac Recent Developments and Future Plans
• 2.5 Pfizer
  • 2.5.1 Pfizer Details
  • 2.5.2 Pfizer Major Business
  • 2.5.3 Pfizer mRNA Flu Vaccine Product and Solutions
  • 2.5.4 Pfizer Recent Developments and Future Plans
• 2.6 Arcturus Therapeutics Holdings
  • 2.6.1 Arcturus Therapeutics Holdings Details
  • 2.6.2 Arcturus Therapeutics Holdings Major Business
  • 2.6.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product and Solutions
  • 2.6.4 Arcturus Therapeutics Holdings Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global mRNA Flu Vaccine Revenue and Share by Players (2026 & 2032)
• 3.2 mRNA Flu Vaccine Players Head Office, Products and Services Provided
• 3.3 mRNA Flu Vaccine Mergers & Acquisitions
• 3.4 mRNA Flu Vaccine New Entrants and Expansion Plans

4 Global mRNA Flu Vaccine Forecast by Region

• 4.1 Global mRNA Flu Vaccine Market Size by Region: 2026 VS 2032
• 4.2 Global mRNA Flu Vaccine Market Size by Region, (2026-2032)
• 4.3 North America
  • 4.3.1 Key Companies of mRNA Flu Vaccine in North America
  • 4.3.2 Current Situation and Forecast of mRNA Flu Vaccine in North America
  • 4.3.3 North America mRNA Flu Vaccine Market Size and Prospect (2026-2032)
• 4.4 Europe
  • 4.4.1 Key Companies of mRNA Flu Vaccine in Europe
  • 4.4.2 Current Situation and Forecast of mRNA Flu Vaccine in Europe
  • 4.4.3 Europe mRNA Flu Vaccine Market Size and Prospect (2026-2032)
• 4.5 Asia-Pacific
  • 4.5.1 Key Companies of mRNA Flu Vaccine in Asia-Pacific
  • 4.5.2 Current Situation and Forecast of mRNA Flu Vaccine in Asia-Pacific
  • 4.5.3 Asia-Pacific mRNA Flu Vaccine Market Size and Prospect (2026-2032)
  • 4.5.4 China
  • 4.5.5 Japan
  • 4.5.6 South Korea
• 4.6 South America
  • 4.6.1 Key Companies of mRNA Flu Vaccine in South America
  • 4.6.2 Current Situation and Forecast of mRNA Flu Vaccine in South America
  • 4.6.3 South America mRNA Flu Vaccine Market Size and Prospect (2026-2032)
• 4.7 Middle East & Africa
  • 4.7.1 Key Companies of mRNA Flu Vaccine in Middle East & Africa
  • 4.7.2 Current Situation and Forecast of mRNA Flu Vaccine in Middle East & Africa
  • 4.7.3 Middle East & Africa mRNA Flu Vaccine Market Size and Prospect (2026-2032)

5 Market Size Segment by Type

• 5.1 Global mRNA Flu Vaccine Market Forecast by Type (2026-2032)
• 5.2 Global mRNA Flu Vaccine Market Share Forecast by Type (2026-2032)

6 Market Size Segment by Application

• 6.1 Global mRNA Flu Vaccine Market Forecast by Application (2026-2032)
• 6.2 Global mRNA Flu Vaccine Market Share Forecast by Application (2026-2032)

7 Research Findings and Conclusion

8 Appendix

• 8.1 Methodology
• 8.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global mRNA Flu Vaccine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The mRNA Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
mRNA Flu Vaccine market is split by Type and by Application. For the period 2026-2032, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type,
mRNA-1010
mRNA-1020
mRNA-1030
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Moderna
BioNTech
Sanofi
Curevac
Pfizer
Arcturus Therapeutics Holdings
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia)
South America
Middle East & Africa